A new role for genetics in cancer therapy-induced cardiomyopathy

(Brigham and Women's Hospital) A team of investigators from Brigham and Women's Hospital and Harvard Medical School finds that genetics may be at play and elucidates rare genetic variants which may influence risk for developing cancer therapy-induced cardiomyopathy.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news